These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23940366)

  • 1. Growth hormone is a cellular senescence target in pituitary and nonpituitary cells.
    Chesnokova V; Zhou C; Ben-Shlomo A; Zonis S; Tani Y; Ren SG; Melmed S
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3331-9. PubMed ID: 23940366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary senescence: the evolving role of Pttg.
    Chesnokova V; Melmed S
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):55-9. PubMed ID: 20153804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage-specific restraint of pituitary gonadotroph cell adenoma growth.
    Chesnokova V; Zonis S; Zhou C; Ben-Shlomo A; Wawrowsky K; Toledano Y; Tong Y; Kovacs K; Scheithauer B; Melmed S
    PLoS One; 2011 Mar; 6(3):e17924. PubMed ID: 21464964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene-induced senescence in pituitary adenomas and carcinomas.
    Alexandraki KI; Munayem Khan M; Chahal HS; Dalantaeva NS; Trivellin G; Berney DM; Caron P; Popovic V; Pfeifer M; Jordan S; Korbonits M; Grossman AB
    Hormones (Athens); 2012; 11(3):297-307. PubMed ID: 22908062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension.
    Mouraret N; Marcos E; Abid S; Gary-Bobo G; Saker M; Houssaini A; Dubois-Rande JL; Boyer L; Boczkowski J; Derumeaux G; Amsellem V; Adnot S
    Circulation; 2013 Apr; 127(16):1664-76. PubMed ID: 23513067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-pituitary growth hormone enables colon cell senescence evasion.
    Chesnokova V; Zonis S; Apaydin T; Barrett R; Melmed S
    Aging Cell; 2024 Aug; 23(8):e14193. PubMed ID: 38724466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma inhibits GH synthesis and secretion and increases apoptosis of pituitary GH-secreting adenomas.
    Bogazzi F; Ultimieri F; Raggi F; Russo D; Vanacore R; Guida C; Viacava P; Cecchetti D; Acerbi G; Brogioni S; Cosci C; Gasperi M; Bartalena L; Martino E
    Eur J Endocrinol; 2004 Jun; 150(6):863-75. PubMed ID: 15191358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K/Akt/mTOR pathway involvement in regulating growth hormone secretion in a rat pituitary adenoma cell line.
    Di Pasquale C; Gentilin E; Falletta S; Bellio M; Buratto M; Degli Uberti E; Chiara Zatelli M
    Endocrine; 2018 May; 60(2):308-316. PubMed ID: 29080043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
    Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
    Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.
    Kumamoto K; Spillare EA; Fujita K; Horikawa I; Yamashita T; Appella E; Nagashima M; Takenoshita S; Yokota J; Harris CC
    Cancer Res; 2008 May; 68(9):3193-203. PubMed ID: 18451145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
    Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
    J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
    Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
    Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.
    Ben-Shlomo A; Deng N; Ding E; Yamamoto M; Mamelak A; Chesnokova V; Labadzhyan A; Melmed S
    J Clin Invest; 2020 Nov; 130(11):5738-5755. PubMed ID: 32673291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced transcriptional activity in the p53 pathway of senescent cells revealed by the MDM2 antagonist nutlin-3.
    Huang B; Vassilev LT
    Aging (Albany NY); 2009 Sep; 1(10):845-54. PubMed ID: 20157557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
    Leontieva OV; Natarajan V; Demidenko ZN; Burdelya LG; Gudkov AV; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13314-8. PubMed ID: 22847439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.
    Chesnokova V; Zonis S; Rubinek T; Yu R; Ben-Shlomo A; Kovacs K; Wawrowsky K; Melmed S
    Cancer Res; 2007 Nov; 67(21):10564-72. PubMed ID: 17975001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
    Hulting AL; Wersäll J; Werner S
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.